These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24296297)

  • 1. Targeted delivery of the RGD-labeled biodegradable polymersomes loaded with the hydrophilic drug oxymatrine on cultured hepatic stellate cells and liver fibrosis in rats.
    Yang J; Hou Y; Ji G; Song Z; Liu Y; Dai G; Zhang Y; Chen J
    Eur J Pharm Sci; 2014 Feb; 52():180-90. PubMed ID: 24296297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.
    Chai NL; Fu Q; Shi H; Cai CH; Wan J; Xu SP; Wu BY
    World J Gastroenterol; 2012 Aug; 18(31):4199-206. PubMed ID: 22919254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats.
    Du SL; Pan H; Lu WY; Wang J; Wu J; Wang JY
    J Pharmacol Exp Ther; 2007 Aug; 322(2):560-8. PubMed ID: 17510318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis.
    Kumar V; Dong Y; Kumar V; Almawash S; Mahato RI
    Theranostics; 2019; 9(25):7537-7555. PubMed ID: 31695785
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon gamma peptidomimetic targeted to hepatic stellate cells ameliorates acute and chronic liver fibrosis in vivo.
    Bansal R; Prakash J; De Ruiter M; Poelstra K
    J Control Release; 2014 Apr; 179():18-24. PubMed ID: 24491909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oxymatrine on experimental hepatic fibrosis and its mechanism in vivo.
    Shi GF; Li Q
    World J Gastroenterol; 2005 Jan; 11(2):268-71. PubMed ID: 15633229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats.
    Li F; Li QH; Wang JY; Zhan CY; Xie C; Lu WY
    J Control Release; 2012 Apr; 159(2):261-70. PubMed ID: 22226772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
    Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arg-gly-asp-mannose-6-phosphate inhibits activation and proliferation of hepatic stellate cells in vitro.
    Wang LS; Chen YW; Li DG; Lu HM
    World J Gastroenterol; 2006 Feb; 12(8):1303-7. PubMed ID: 16534891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
    J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha.
    Wu CS; Piao XX; Piao DM; Jin YR; Li CH
    World J Gastroenterol; 2005 Jan; 11(1):122-6. PubMed ID: 15609410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and Biodistribution of GDC-0449 Loaded Micelles in Normal and Liver Fibrotic Mice.
    Dutta R; Kumar V; Peng Y; Evande RE; Grem JL; Mahato RI
    Pharm Res; 2017 Mar; 34(3):564-578. PubMed ID: 27995525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanobody-functionalized PEG-b-PCL polymersomes and their targeting study.
    Zou T; Dembele F; Beugnet A; Sengmanivong L; Trepout S; Marco S; de Marco A; Li MH
    J Biotechnol; 2015 Nov; 214():147-55. PubMed ID: 26433047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
    Moreno M; Gonzalo T; Kok RJ; Sancho-Bru P; van Beuge M; Swart J; Prakash J; Temming K; Fondevila C; Beljaars L; Lacombe M; van der Hoeven P; Arroyo V; Poelstra K; Brenner DA; Ginès P; Bataller R
    Hepatology; 2010 Mar; 51(3):942-52. PubMed ID: 20044807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
    Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arg-Gly-Asp (RGD) peptide ameliorates carbon tetrachloride-induced liver fibrosis via inhibition of collagen production and acceleration of collagenase activity.
    Kotoh K; Nakamuta M; Kohjima M; Fukushima M; Morizono S; Kobayashi N; Enjoji M; Nawata H
    Int J Mol Med; 2004 Dec; 14(6):1049-53. PubMed ID: 15547672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.